Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Predicting Multiple Sclerosis: Scientific Promise, Clinical Limits, and Future Opportunities
Genetics
Predicting Multiple Sclerosis: Scientific Promise, Clinical Limits, and Future Opportunities

07, Jun 2026

2
Predicting Multiple Sclerosis: Scientific Promise, Clinical Limits, and Future Opportunities
Genetics
Gene–Environment Interactions in Multiple Sclerosis: Insights from UK Biobank

06, Jun 2026

3
Polygenic Risk Scoring for Multiple Sclerosis: Ancestry-Dependent Performance and the Need for Equitable Genomic Prediction
Genetics
Polygenic Risk Scoring for Multiple Sclerosis: Ancestry-Dependent Performance and the Need for Equitable Genomic Prediction

05, Jun 2026

4
Genetic Architecture of Multiple Sclerosis Across South Asian and African Ancestries
Genetics
Genetic Architecture of Multiple Sclerosis Across South Asian and African Ancestries

04, Jun 2026

5
Polygenic Risk Scores and the Lifetime Risk of Multiple Sclerosis: Insights from a Dutch Birth-Year Cohort
Genetics
Polygenic Risk Scores and the Lifetime Risk of Multiple Sclerosis: Insights from a Dutch Birth-Year Cohort

03, Jun 2026

Categories:
Genetics
Can We Predict Who Benefits from Glatiramer Acetate in MS?
Genetics
Can We Predict Who Benefits from Glatiramer Acetate in MS?

23, Jul 2025

Can We Predict Who Will Benefit From Fingolimod? A Step Toward Personalized Treatment in Multiple Sclerosis
Genetics
Can We Predict Who Will Benefit From Fingolimod? A Step Toward Personalized Treatment in Multiple Sclerosis

24, Jul 2025

Towards Personalized Treatment for Multiple Sclerosis: How Your Genes Can Help Choose the Right Therapy
Genetics
Towards Personalized Treatment for Multiple Sclerosis: How Your Genes Can Help Choose the Right Therapy

26, Jul 2025

Code of Multiple Sclerosis: New Insights into PPMS, RRMS, and the Promise of Ocrelizumab
Genetics
Code of Multiple Sclerosis: New Insights into PPMS, RRMS, and the Promise of Ocrelizumab

26, Jul 2025